Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits.
Diabetes care; 2010 Feb;33(2):428-33. PMID: 20103558
Department of Medicine, Samuel Lunenfeld Research Institute, University of Toronto, Toronto, Ontario, Canada. d.drucker@utoronto.ca
Category: